Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
White Plains, N.Y. (May 15, 2014) - Francie Heller, managing partner at Heller Advisory, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS), effective July 1, 2014. Her term will run through June 30, 2017.
Heller has more than two decades of financial experience in both the public and private sectors. Heller has served as managing director at Houlihan Lokey, where she ran the pension, endowment and foundation advisory group. Prior to that, Heller was a managing director at Chilton Investment Company. Before Chilton, she served as senior managing director at Bear Stearns & Co., Inc., and president of MBIA Municipal Investors Service Corporation. Heller was also an education director in the New York City public schools for several years.
Heller earned a bachelor's degree from Boston University, a master's equivalent degree from the University of Georgia, and a professional diploma from Fordham University. She currently serves on several boards, as chairman of the investment committee for Furman University, and on the LLS investment committee. In addition, Heller is an advisor to the Government Finance Officer Association?s committee on retirement and benefits administration
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.